MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Net Cash Flow came in at $50.9 million in Q4 2025, up 351.21% YoY from $11.3 million in Q4 2024, and up 491.88% on a QoQ basis from -$13.0 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Net Cash Flow data on file, last reported at $50.9 million in Q4 2025.

  • Quarterly Net Cash Flow rose 351.21% year-over-year to $50.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$38.2 million (down 44.23% YoY) and the FY2025 annual result came in at -$38.2 million, down 44.23% from the prior year.
  • Net Cash Flow climbed to $50.9 million in Q4 2025, from -$13.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $64.3 million in Q4 2023 to a low of -$47.2 million in Q1 2023.
  • A 5-year average of -$7.3 million and a median of -$16.1 million in 2024 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2023 — Net Cash Flow surged 86848.65% — and 2025, when it slumped 244.83%.
  • Tracing MGTX's Net Cash Flow over 5 years: stood at -$5.2 million in 2021, then surged by 101.41% to $74000.0 in 2022, then surged by 86848.65% to $64.3 million in 2023, then tumbled by 131.47% to -$20.2 million in 2024, then jumped by 351.21% to $50.9 million in 2025.
  • The last three Net Cash Flow figures came in at $50.9 million (Q4 2025), -$13.0 million (Q3 2025), and -$39.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 50.84 Mn
Sep 30, 2025 -12.99 Mn
Jun 30, 2025 -39.26 Mn
Mar 31, 2025 -36.83 Mn
Dec 31, 2024 -20.25 Mn
Sep 30, 2024 23.62 Mn
Jun 30, 2024 -19.18 Mn
Mar 31, 2024 -10.67 Mn
Dec 31, 2023 64.34 Mn
Sep 30, 2023 -28.38 Mn
Jun 30, 2023 23.96 Mn
Mar 31, 2023 -47.23 Mn
Dec 31, 2022 74,000.00
Sep 30, 2022 42.21 Mn
Jun 30, 2022 -41.81 Mn
Mar 31, 2022 -23.34 Mn
Dec 31, 2021 -5.25 Mn
Sep 30, 2021 -29.03 Mn
Jun 30, 2021 -26.61 Mn
Mar 31, 2021 -9.65 Mn